Seniors with Skin Cancer FACE Medicare Cuts

Express your Opinion:  https://bit.ly/oppose-skin-cancer-medicare-cuts

Learn more:  https://bit.ly/medicare-cuts-skin-cancer

The landscape of healthcare in the United States is ever-evolving, with policy changes and budget reallocations frequently impacting the coverage and services available to millions. Recently, the Centers for Medicare & Medicaid Services (CMS) announced significant cuts to Medicare coverage, specifically affecting seniors battling non-melanoma skin cancer. This decision has sparked concern among healthcare professionals, patients, and advocacy groups alike. Understanding the implications of these cuts is crucial for affected individuals and their families, as well as for policymakers aiming to address the needs of our aging population.

Non-melanoma skin cancers, primarily basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), are among the most common cancers diagnosed in the United States. While often less aggressive than melanoma, these cancers can lead to severe health complications if not treated appropriately. CMS's recent decision to reduce Medicare coverage for therapies related to non-melanoma skin cancer has raised alarms for several reasons.